|
|
|
|
Drug-Drug Interactions Between Next Generation Direct Acting Antivirals
ABT-493 and ABT-530 with Cyclosporine or Tacrolimus in Healthy Subjects
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco, CA
Matthew P. Kosloski, Sandeep Dutta, Weihan Zhao, David Pugatch, Armen Asatryan, Jens Kort, Wei Liu AbbVie Inc., North Chicago, Illinois, United States
|
|
|
|
|
|
|